107 related articles for article (PubMed ID: 21724925)
1. When good drugs turn weirdly bad.
Mandell BF
Cleve Clin J Med; 2011 Jul; 78(7):426. PubMed ID: 21724925
[No Abstract] [Full Text] [Related]
2. Rash from hepatitis C treatment.
Tang DM; Ward L
Cleve Clin J Med; 2011 Jul; 78(7):472-4. PubMed ID: 21724930
[No Abstract] [Full Text] [Related]
3. [Drug-induced exanthema caused by pegylated interferon-alpha 2b].
Meller S; Erhardt A; Auci A; Neumann NJ; Homey B
Hautarzt; 2003 Oct; 54(10):992-3. PubMed ID: 14513254
[No Abstract] [Full Text] [Related]
4. A case of irreversible alopecia associated with ribavirin and peg-interferon therapy.
Shafa S; Borum ML; Igiehon E
Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):122-3. PubMed ID: 19959941
[No Abstract] [Full Text] [Related]
5. Severe allergic eczema due to pegylated alpha-interferon may abate after switching to daily conventional alpha-interferon.
Veldt BJ; Schalm SW; Janssen HL
J Clin Gastroenterol; 2007 Apr; 41(4):432. PubMed ID: 17413616
[No Abstract] [Full Text] [Related]
6. Erythema gyratum repens induced by pegylated interferon alfa for chronic hepatitis C.
Rongioletti F; Fausti V; Parodi A
Arch Dermatol; 2012 Oct; 148(10):1213-4. PubMed ID: 23069974
[No Abstract] [Full Text] [Related]
7. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
Quinn D; Kuchler E; Deming P; Arora S
Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
[No Abstract] [Full Text] [Related]
8. [Side effects of interferon-based therapy for chronic hepatitis C virus infection and clinical management of them].
Iwasaki Y; Ikeda F; Yamamoto K
Nihon Rinsho; 2011 May; 69 Suppl 4():215-20. PubMed ID: 22096922
[No Abstract] [Full Text] [Related]
9. Clinical and immunological features of hepatitis C treatment-associated dermatitis in 36 prospective cases.
Lübbe J; Kerl K; Negro F; Saurat JH
Br J Dermatol; 2005 Nov; 153(5):1088-90. PubMed ID: 16225644
[No Abstract] [Full Text] [Related]
10. FDA notifications. Renal impairment addressed in labeling.
AIDS Alert; 2011 Nov; 26(11):131. PubMed ID: 22164522
[No Abstract] [Full Text] [Related]
11. Interferon-alpha induced psoriasis in a teenager.
Mendieta KL; Irfan M; Fernandez Faith E
Pediatr Dermatol; 2018 Mar; 35(2):e136-e137. PubMed ID: 29575077
[TBL] [Abstract][Full Text] [Related]
12. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with Peg interferon alfa-2a and ribavirin.
Ennaifer R; Cheikh M; Romdhane H; Hefaiedh R; Ben Nejma H; Bel Hadj N
Tunis Med; 2014 Jan; 92(1):42-3. PubMed ID: 24879173
[No Abstract] [Full Text] [Related]
13. [Early interruption of triple therapy with telaprevir in chronic hepatitis C due to severe adverse effects does not necessarily lead to treatment failure].
Virolés Torrent S; López Nuñez C; Hombrados Verde M; Figa Francesch M; Ferri Iglesias MJ; Louvriex Freire R; Acero Fernández D
Gastroenterol Hepatol; 2015 Feb; 38(2):78-81. PubMed ID: 24948444
[No Abstract] [Full Text] [Related]
14. Nonischemic cardiomyopathy related to pegylated interferon and ribavirin.
Choy-Shan A; Berezovskaya S; Zinn A; Sedlis SP; Bini EJ
Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1438-40. PubMed ID: 19907230
[No Abstract] [Full Text] [Related]
15. Severe renal impairment during triple therapy with telaprevir.
Carrier P; Chambaraud T; Vong C; Guillaudeau A; Debette-Gratien M; Jacques J; Legros R; Sautereau D; Essig M; Loustaud-Ratti V
Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):e69-71. PubMed ID: 24461554
[No Abstract] [Full Text] [Related]
16. [A doubtful case of anterior uveitis drug related].
Palop Larrea V; Morales Olivas JM; Martínez-Mir I
Med Clin (Barc); 2003 Nov; 121(16):636-7; author reply 637. PubMed ID: 14636544
[No Abstract] [Full Text] [Related]
17. Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege.
Ito T; Suzuki T; Funakoshi A; Tokura Y
Eur J Dermatol; 2014; 24(5):631-3. PubMed ID: 25115439
[No Abstract] [Full Text] [Related]
18. [Side effects of therapy and management].
Ciocca M; Daruich J; Fernández N
Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S59-62. PubMed ID: 20214307
[No Abstract] [Full Text] [Related]
19. Allergic sensitization to pegylated interferon-α results in drug eruptions.
Meller S; Gerber PA; Kislat A; Hevezi P; Göbel T; Wiesner U; Kellermann S; Bünemann E; Zlotnik A; Häussinger D; Erhardt A; Homey B
Allergy; 2015 Jul; 70(7):775-83. PubMed ID: 25831972
[TBL] [Abstract][Full Text] [Related]
20. Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C.
Oiso N; Sato M; Kawada A
J Dermatol; 2013 Sep; 40(9):772-3. PubMed ID: 23855823
[No Abstract] [Full Text] [Related]
[Next] [New Search]
